TYSON HARRIS: Open Payments
NPI 1588905699 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,914 in 118 payments from 19 companies in 2025. Trend: 2023 $1,407 · 2024 $3,173 · 2025 $1,914
Food & beverage: $1,914
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 39 | $437 |
| ABBVIE INC. | 18 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $213 |
| PFIZER INC. | 15 | $207 |
| Janssen Biotech, Inc. | 3 | $130 |
| Regeneron Healthcare Solutions, Inc. | 5 | $127 |
| Phathom Pharmaceuticals, Inc. | 6 | $91 |
| GENZYME CORPORATION | 4 | $68 |
| Madrigal Pharmaceuticals | 4 | $66 |
| Gilead Sciences, Inc. | 2 | $53 |
Products named: WATCHMAN FLX, DUPIXENT, ENTYVIO, CREON, VELSIPITY, TREMFYA, VOQUEZNA, LINZESS.
Industry payments across ID — which companies pay providers there.
